Sequential E2s Drive Polyubiquitin Chain Assembly on APC Targets  by Rodrigo-Brenni, Monica C. & Morgan, David O.
Sequential E2s Drive Polyubiquitin Chain
Assembly on APC Targets
Monica C. Rodrigo-Brenni1 and David O. Morgan1,*
1Departments of Physiology and Biochemistry and Biophysics, University of California, San Francisco, CA 94158, USA
*Correspondence: david.morgan@ucsf.edu
DOI 10.1016/j.cell.2007.05.027SUMMARY
The anaphase-promoting complex (APC), or
cyclosome, is an E3 ubiquitin-protein ligase
that collaborates with E2 ubiquitin-conjugating
enzymes to assemble polyubiquitin chains on
proteins important for cell-cycle progression.
It remains unclear how the APC—or many other
E3s—promotes the multiple distinct reactions
necessary for chain assembly. We addressed
this problem by analyzing APC interactions
with different E2s. We screened all budding
yeast E2s as APC coenzymes in vitro and found
that two, Ubc4 and Ubc1, are the key E2 part-
ners for the APC. These proteins display strik-
ingly different but complementary enzymatic
behaviors: Ubc4 supports the rapid monoubi-
quitination of multiple lysines on APC targets,
while Ubc1 catalyzes K48-linked polyubiquitin
chain assembly on preattached ubiquitins.
Mitotic APC function is lost in yeast strains
lacking both Ubc1 and Ubc4. E2-25K, a human
homolog of Ubc1, also promotes APC-depen-
dent chain extension on preattached ubiquitins.
We propose that sequential E2 proteins cata-
lyze K48-linked polyubiquitination and thus
proteasomal destruction of APC targets.
INTRODUCTION
Protein ubiquitination is a critical regulatory modification,
particularly in the control of protein degradation, whereby
the addition of multiple ubiquitins to a protein triggers
recognition and destruction by the proteasome (Kerscher
et al., 2006; Pickart and Eddins, 2004). This process is
catalyzed by an enzymatic cascade involving a ubiquitin-
activating enzyme (E1), a ubiquitin-conjugating enzyme
(E2), and a ubiquitin-protein ligase (E3). E1 employs ATP
hydrolysis to catalyze formation of a thioester bond
between the C terminus of ubiquitin and an active-site
cysteine on E1. The E1-ubiquitin conjugate binds to an
E2, resulting in transfer of the ubiquitin C terminus from
E1 to a cysteine in the E2. An E3 then promotes transferof the ubiquitin from the E2-ubiquitin conjugate to a lysine
side chain on the target protein. Repeated cycles of this
reaction can lead to the attachment of ubiquitins to several
lysines on the target and to specific lysines on ubiquitin
itself, resulting in polyubiquitin chains.
E3s contain specific binding sites for two substrates: an
E2-ubiquitin conjugate and a protein target. In the case of
the large RING-domain family of E3s, the 3-amino group
on a lysine side chain in the target protein attacks the
E2-ubiquitin thioester linkage, resulting in the formation
of an isopeptide bond between the C terminus of ubiquitin
and the target lysine. Catalysis depends on residues
provided by the E2 (Passmore and Barford, 2004; Pickart
and Eddins, 2004; Wu et al., 2003). RING-domain ligases
facilitate the reaction by bringing the two substrates in
close proximity and possibly by activating the catalytic
function of the E2 (Ozkan et al., 2005).
Polyubiquitin chain formation results from a linkage
between the C terminus of one ubiquitin and a lysine
side chain in another (Hochstrasser, 2006; Pickart and
Fushman, 2004). Ubiquitin contains several lysines that
can be used as ubiquitination sites (Peng et al., 2003),
but most chains are linked through lysine 48 (K48) or lysine
63 (K63). A K48-linked chain of four or more ubiquitins
provides an important recognition signal for destruction
in the proteasome (Thrower et al., 2000). In most cases,
polyubiquitin chain assembly is thought to occur by the
sequential addition of ubiquitin to a lysine on a ubiquitin
already attached to the target (Hochstrasser, 2006).
Polyubiquitin chain assembly by sequential addition
involves two reactions with different lysine specificities.
The monoubiquitination reaction—direct attachment of
ubiquitin to the protein target—often occurs at multiple
lysines in a somewhat random pattern that does not
seem to depend on the amino acid sequence context
(King et al., 1996; Petroski and Deshaies, 2003). In con-
trast, the polyubiquitination reaction typically requires
modification of a single specific lysine, such as K48, in
ubiquitin. Many E3s are capable of promoting both of
these reactions—raising the intriguing question of how
a single E3 can carry out two reactions of such distinct
specificity. The RING-domain ligase SCF solves this prob-
lem by collaborating with a single E2, Cdc34, that cata-
lyzes both the slow attachment of ubiquitin to a lysine in
the substrate as well as the rapid extension of a K48-
linked polyubiquitin chain (Petroski and Deshaies, 2005).Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc. 127
In another case, the two steps of chain assembly involve
entirely different enzymes: the ubiquitination of PCNA
begins with one E3-E2 pair that places the initial ubiquitin
on the target, after which a different E3-E2 complex
extends a K63-linked ubiquitin chain (Eddins et al., 2006;
Hoege et al., 2002).
The anaphase-promoting complex (APC), or cyclo-
some, is a large, multisubunit RING-domain E3 required
for the completion of mitosis in all eukaryotes (Morgan,
2007; Peters, 2006; Thornton and Toczyski, 2006). The
APC ubiquitinates securin, allowing chromosome segre-
gation, and mitotic cyclins, promoting mitotic exit and
the establishment of G1. APC activity is regulated by its
association with activator subunits, Cdc20 and Cdh1,
which help mediate the interaction between the APC
and specific destruction sequences on its substrates. Dur-
ing mitosis, the APC is activated first by association with
Cdc20, which targets securin and some cyclins at the
metaphase-to-anaphase transition. Cdh1 is activated
later in mitosis, resulting in further cyclin destruction and
the maintenance of APC activity in G1.
A major unsolved problem in APC biology is the identity
of the E2s that collaborate with the APC in vivo. In higher
eukaryotes, APC function is thought to depend on at least
two E2 proteins whose names in human cells are UbcH5
(also known as Ubc4) and UbcH10 (also named UbcX
and E2-C in some species; Aristarkhov et al., 1996;
Hershko et al., 1994; King et al., 1995; Kirkpatrick et al.,
2006; Mathe et al., 2004; Townsley et al., 1997; Yu et al.,
1996). Homologs of these two proteins are both essential
for timely mitotic progression and cyclin destruction in
fission yeast (Seino et al., 2003). A recent analysis sug-
gests that vertebrate UbcH5 and UbcH10 promote mono-
ubiquitination of APC targets as well as the assembly of
short polyubiquitin chains that display little lysine specific-
ity (Kirkpatrick et al., 2006). K48-specific polyubiquitina-
tion by purified APC has not been observed, suggesting
either that it does not occur in vivo or that it depends on
E2s that remain to be identified.
In the budding yeast, Saccharomyces cerevisiae, the
relevant E2s are not clear. The yeast genome encodes
proteins that are related to both UbcH5 and UbcH10
(Ubc4 and Ubc11, respectively), but cells depleted of
both enzymes progress normally through the cell cycle
(Townsley and Ruderman, 1998). Ubc4 has a close homo-
log in yeast, Ubc5, but cells lacking both Ubc4 and Ubc5
are viable, although their growth is impaired (Seufert and
Jentsch, 1990). The same is true of cells depleted of
both Ubc5 and Ubc11. Thus, there is no single or multiple
E2 defect known to result in a complete loss of APC func-
tion, suggesting that we have not yet found all the E2s that
collaborate with the yeast APC.
Budding yeast Ubc4 is a well-established APC-depen-
dent E2 that has been used in all previous studies of yeast
APC enzymology (Carroll and Morgan, 2005; Passmore
et al., 2005). Deletion of UBC4 is lethal in strains with
diminished APC activity (Irniger et al., 1995). However,
Ubc4-dependent reactions with the APC or other E3s do128 Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc.not result in efficient formation of polyubiquitin (Carroll
and Morgan, 2002; Wu et al., 2003), indicating that other
E2s may be required to promote chain formation by the
APC.
To clarify the mechanisms by which the APC modifies
its targets, we identified and characterized the E2s that
work with the budding yeast APC. Two E2s were found
to be critical: Ubc4 and Ubc1. A detailed comparison of
their activities revealed that they act in sequence to
promote the two steps in polyubiquitin chain assembly:
Ubc4 monoubiquitinates APC targets at multiple lysines,
providing a substrate upon which Ubc1 assembles K48-
linked polyubiquitin chains.
RESULTS
Identification of APC-Dependent E2s
The yeast genome encodes 13 ubiquitin-conjugating
enzyme family members (Ubc1–Ubc13). We purified
each protein and tested its activity with the APC in vitro.
E2s were purified from a library of yeast strains carrying
TAP-tagged proteins under the control of their endoge-
nous promoters (Ghaemmaghami et al., 2003). Seven of
the thirteen E2 proteins were readily prepared from
extracts of proliferating cells (Figure 1A). Of the remaining
six E2s, Ubc6 and Ubc7 were present in denaturing
lysates but could not be recovered from native lysates,
presumably because these two enzymes participate in
the ERAD pathway and are connected to the ER mem-
brane (Biederer et al., 1997; Sommer and Jentsch, 1993).
The remaining four enzymes (Ubc5, Ubc10, Ubc11, and
Ubc12) were not detected in denatured whole lysates
and thus appear to be poorly expressed in cycling cells.
The seven Ubc enzymes present in native lysates from
log-phase cells were purified and added to reactions
containing E1, ATP, ubiquitin, APC, Cdh1, and radiola-
beled securin to monitor ubiquitination. As expected,
TAP-tagged Ubc4 purified from yeast promoted APC
activity toward securin. Of the remaining six E2s tested,
only Ubc1 also supported robust APC-dependent securin
ubiquitination (Figure 1A).
We also tested the E2s that we could not detect in
proliferating cells. Ubc11 and Ubc12 were produced by
overexpression in yeast. Ubc12, as expected for a
Nedd1-dependent enzyme, was not able to conjugate
ubiquitin (data not shown; Liakopoulos et al., 1998).
Ubc11 promoted a low level of APC-dependent ubiquiti-
nation of securin and sea urchin cyclin B (Figure S1A;
data not shown). We also tested Ubc5 produced in bacte-
ria. As expected from its high degree of homology to
Ubc4, Ubc5 also promoted APC-dependent ubiquitina-
tion of both substrates (Figure S1B; data not shown).
Like Ubc4, both Ubc11 and Ubc5 catalyzed the addition
of relatively few ubiquitins per substrate. Although
Ubc11 and Ubc5 are able to support some APC activity
in vitro, their undetectable expression in proliferating cells,
their increased expression in meiosis, and the minimal ef-
fects of their gene deletions all suggested to us that they
Figure 1. Ubc1 Is an APC-Dependent E2
Enzyme
(A) The seven indicated Ubc enzymes (100–
200 ng) were purified from yeast and incubated
for 1 hr at room temperature in duplicate
APCCdh1-dependent ubiquitination assays
using purified 35S-securin as the substrate.
Control reactions were performed with a
mock-purified lysate from a strain lacking
a TAP-tagged E2 () or Ubc4 purified from
bacteria (+). Final lanes indicate negative con-
trol reactions in which substrate was incubated
with recombinant Ubc4 alone (APC) or with
APC alone (E2).
(B) Recombinant Ubc4 (1.25 mg) or Ubc1
(1.0 mg) was incubated for 15 min with E1,
ATP, and ubiquitin; added to the APCCdh1 mix
containing 35S-securin; and incubated for the
indicated time. Thirty minute control reactions
() lacked APC.
(C) Recombinant Ubc4 (0.5 mg) or Ubc1 (1.0 mg)
was incubated with E1, ATP, and ubiquitin for
15 min and then added to APCCdh1 reactions
containing the indicated 35S-labeled sub-
strates for 15 min at room temperature. Hsl1
is a truncated protein (residues 667–882), and
cyclin B1 is an N-terminal fragment of sea
urchin cyclin B1 (residues 11–113).are not critical APC partners in mitosis (Chu et al., 1998;
Seufert and Jentsch, 1990; Townsley and Ruderman,
1998). We therefore focused our efforts on Ubc1 and
Ubc4.
Ubc1 and Ubc4 Generate Different
Reaction Products
We purified 6-histidine-tagged Ubc1 and Ubc4 from
E. coli by metal affinity chromatography. Both enzymes
accepted ubiquitin from E1 (see Figure 2A below) and
supported APC-dependent ubiquitination of securin
in vitro in a purified system (Figure 1B). Ubc4 was able
to completely deplete the initial substrate under these
conditions, while Ubc1 used only a small fraction of the
initial substrate. Ubc4 therefore displays greater activity
toward unmodified substrate. However, Ubc1 promoted
the formation of higher molecular weight products than
Ubc4, indicating that more ubiquitins were added per
substrate molecule. Ubc1 also generated higher molecu-
lar weight products in reactions with other substrates
(Figure 1C).
The activating subunit in these experiments was Cdh1,
which is more readily prepared in active form than Cdc20.
Similar results were obtained using Cdc20 that was pro-
duced by translation in vitro (Figure S2), indicating that
the distinct behaviors of Ubc1 and Ubc4 are seen with
both activating subunits.
Ubc1 Promotes the Formation of K48-Linked
Polyubiquitin Chains
To test whether the highly ubiquitinated products gener-
ated by Ubc1 were polyubiquitin chains, we carried outreactions with methylated ubiquitin in which all seven
lysines in ubiquitin are chemically blocked and thus not
available for chain formation. Incubation of methyl-ubiqui-
tin with Ubc4 or Ubc1 resulted in the formation of E2-Ub
conjugates that could be detected on a nonreducing
polyacrylamide gel, confirming that both E2s are able
to accept the different ubiquitin species equivalently
(Figure 2A).
We first used the N terminus of sea urchin cyclin B as
a substrate.With Ubc4 as the E2 in the reaction, wemainly
observed mono-, di-, and triubiquitinated species in reac-
tions with wild-type ubiquitin (Figure 2B). As seen in our
previous work, when methyl-ubiquitin was used, triubiqui-
tinated species were slightly reduced but the mono- and
diubiquitinated species were unaffected (Carroll and Mor-
gan, 2002). Thus, Ubc4 primarily promotes monoubiquiti-
nation of multiple lysines in cyclin B but is not effective in
promoting chain formation. The slight reduction in the
triubiquitinated species aswell as the loss of the heteroge-
neous bands above the triubiquitinated species suggest
that limited chain formation did occur.
We carried out the same analysis with Ubc1. Reaction
products with wild-type ubiquitin included at least eight
ubiquitinated species, present in roughly equal amounts.
Only a single band was observed in reactions with
methyl-ubiquitin, indicating that the higher species seen
with unmodified ubiquitin are polyubiquitinated. Thus,
Ubc1 catalyzes polyubiquitin chain formation.
The same result was obtained using yeast securin as
substrate, although in the case of Ubc4 with ubiquitin or
methyl-ubiquitin the pattern was different, indicating that
some polyubiquitin chains were present (Figure 2C).Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc. 129
Figure 2. Ubc1 Promotes the Formation
of K48-Linked Ubiquitin Chains
(A) To confirm that they display normal
ubiquitin-conjugating activity, purified Ubc4
(1.25 mg) or Ubc1 (1.25 mg) was incubated with
E1, ATP, and 5 mg of the indicated ubiquitin
species for 15 min at room temperature. Reac-
tions were stopped in SDS sample buffer
lacking DTT and analyzed by nonreducing
SDS-PAGE and Coomassie blue staining. The
position of the protein with or without ubiquitin
is indicated.
(B) The reactions from (A) were used in ubiquiti-
nation reactions. APC, Cdh1, and 125I-cyclin B
were added to the E1/E2 mix and incubated
for 30 min at room temperature. The reactions
were stoppedbyaddition ofSDSsamplebuffer,
analyzed by SDS-PAGE, and visualized with
a PhosphorImager. The number of ubiquitins
on cyclin is indicated.
(C) Same reactions as in (B) but using purified
35S-securin as the substrate.We next carried out reactions with three different ubiq-
uitin point mutants in which single lysines were mutated
(K29R, K48R, and K63R). All mutants were conjugated
efficiently to both Ubc1 and Ubc4 (Figure 2A). In Ubc4-
dependent reactions with these point mutants, the pattern
of ubiquitination was the same as that with wild-type ubiq-
uitin, indicating that the few chain linkages in these reac-
tions were not occurring at specific lysines in ubiquitin
(Figures 2B and 2C). In reactions with Ubc1, however,
the K48R mutant specifically lacked polyubiquitinated
species, indicating that Ubc1-dependent chains are
linked at lysine 48.
Ubc1 Catalyzes Processive Modification
of Preubiquitinated Substrate
Our studies suggested that Ubc1 catalyzes the formation
of polyubiquitin chains, but turnover of unmodified sub-
strate into ubiquitinated species appeared slower than
that with Ubc4 (Figure 1B). We characterized these differ-
ences further by analyzing substrate ubiquitination at
various concentrations of Ubc4 and Ubc1 (Figure 3A).
Half-maximal stimulation of cyclin ubiquitination occurred
at roughly equal concentrations of the two E2s (1.19 ±
0.12 mM Ubc1 and 2.80 ± 0.32 mM Ubc4; Figure 3B).
Most importantly, at saturating E2 concentrations the
rate of cyclin turnover (that is, depletion of unmodified
substrate) was about 10-fold higher with Ubc4 than with
Ubc1, consistent with the earlier indication that Ubc4
was able to convert more original substrate into ubiquiti-
nated species (Figure 1B).
To assess processivity in these reactions, we also
calculated the amounts of ubiquitin added per molecule
of modified cyclin B (Figure 3C; Carroll and Morgan,
2005). As anticipated, Ubc1 was 2- to 3-fold more proces-
sive than Ubc4 by this measure.130 Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc.A likely explanation for these results is that the depletion
of cyclin in these assays is limited by the attachment of the
first ubiquitin; that is, the rate of substrate depletion is
determined by the rate at which the first ubiquitin is added
to an unmodified substrate. Given its preference for K48
of ubiquitin, Ubc1 might have low activity in this first step
but have much higher activity in subsequent steps with
substrates that are already ubiquitinated. To test this
possibility, we isolated preubiquitinated species from the
products of a Ubc4-dependent reaction, which generally
produces equal amounts of mono-, di-, and triubiquiti-
nated species (for examples, see Figures 2B and 3A).
We isolated these species by separating reaction prod-
ucts on a polyacrylamide gel and then extracting radio-
labeled proteins from excised gel fragments. Different
species were then used in reactions with either Ubc1 or
Ubc4. As we showed previously (Carroll and Morgan,
2002), Ubc4 did not display a preference for preubiquiti-
nated substrates (Figure 4A). In contrast, Ubc1 had signif-
icantly higher activity with substrates that were already
ubiquitinated, using monoubiquitinated cyclin B at least
10-fold more rapidly than unmodified cyclin B (Figures
4B and 4C).
When we compared the rate of ubiquitin incorporation
as opposed to cyclin turnover, we found that Ubc1 was
twice as fast as Ubc4 when monoubiquitinated cyclin
was the substrate (Figure 4D). This observation further
suggests that Ubc1 prefers to make chains and that
the slow, rate-limiting step in Ubc1 reactions with
unmodified substrate is the addition of the first ubiquitin
to a lysine on the substrate. Once the substrate carries
a ubiquitin, however, Ubc1 catalyzes more rapid
ubiquitin transfer (through a K48 linkage) than Ubc4
(which modifies nonspecific lysines in the substrate or
ubiquitin).
Figure 3. Ubc1 Is More Processive Than
Ubc4
(A) Recombinant Ubc4 (4.8 nM to 48 mM in
equal steps) or Ubc1 (6.6 nM to 66 mM in equal
steps) was added to E1, ATP, and ubiquitin and
incubated for 15 min at room temperature. The
E1/E2 mix was added to the APCCdh1 mix con-
taining 125I-cyclin B and allowed to react until
no more than 2% of the initial substrate was
used. Reactions were stopped by addition of
SDS sample buffer, analyzed by SDS-PAGE,
and visualized with a PhosphorImager.
(B) The rate at which cyclin was converted to
any ubiquitinated species was determined by
quantifying the total amount of ubiquitinated
substrate. For Ubc4 reactions, the mono-, di-,
and triubiquitinated species were quantified,
while for Ubc1, the eight major ubiquitinated
species were quantified. Data were fit to a rect-
angular hyperbola using the ligand-binding
module providedwith SigmaPlot. This data is representative of three independent experiments. The inset provides a scaled version of theUbc1 curve.
(C) Processivity was determined by calculating the ratio of ubiquitin to cyclin in the products as described (Carroll and Morgan, 2005). Data were fit to
a rectangular hyperbola as in (B).These results suggest that Ubc4 andUbc1 act synergis-
tically in the ubiquitination of APC targets. We tested this
hypothesis by measuring APC-dependent ubiquitination
of cyclin B in the presence of both E2 enzymes under
limiting APC conditions (Figure 4E). When we measured
the appearance of polyubiquitinated cyclin carrying
more than three ubiquitins, we observed that chain forma-
tion was far more rapid in the presence of both E2s than it
was in the presence of either E2 alone (Figure 4F). This
high polyubiquitination activity was specific to the combi-
nation of Ubc4 and Ubc1, as it was not seen in reactions
with twice the amount of Ubc4 alone or Ubc1 alone
(data not shown). These data suggest that Ubc4 and
Ubc1 can act sequentially, with Ubc4 products being
extended by Ubc1 as seen in Figure 4B.
Measurements of the total turnover of unmodified cyclin
B revealed that Ubc4 alone was better at converting cyclin
B to ubiquitinated species than either Ubc1 alone or Ubc1
and Ubc4 together (Figure 4G). Ubc1 therefore inhibits the
ability of Ubc4 to modify the substrate under these condi-
tions of limiting APC levels, as might be expected if the
two E2s compete for the same or overlapping binding
sites on the APC.
The UBA Domain of Ubc1 Contributes
to the Processivity of Chain Assembly
Ubc1 is unique among the yeast E2s in that it contains not
only a ubiquitin-conjugating (UBC) domain but also a
ubiquitin-associated (UBA) domain at its C terminus
(Merkley and Shaw, 2004). Previous studies have shown
that a deletion of the UBA domain on Ubc1 alters the
pattern of its autoubiquitination, but its function has not
been assessed in an E3-dependent reaction (Hodgins
et al., 1996). UBA domains bind ubiquitin (Hicke et al.,
2005), and thus a reasonable hypothesis is that the UBA
domain of Ubc1 aids in its ability to form polyubiquitinchains. We tested this possibility by creating a version of
Ubc1 that lacks this domain, Ubc1-DUBA, and produced
it in bacteria with a C-terminal 6-histidine tag. This trun-
cated protein was as effective as Ubc1 in the conjugation
of ubiquitin and ubiquitin mutants (data not shown),
indicating that the core ubiquitin-conjugating activity of
Ubc1 does not depend on the UBA domain.
As seen in Figure 5A, removal of the UBA domain
resulted in a significant decrease in the number of ubiqui-
tins incorporated into an APC substrate, although the
number of ubiquitins was still greater than that seen with
Ubc4 (compare Figures 2B and 5A). The distribution of
products was altered: shorter products were more
common than longer products in the case of Ubc1-
DUBA, whereas full-length Ubc1 tended to generate equal
amounts of the different species. The UBA domain is
therefore required for the full processivity of Ubc1.
Like full-length Ubc1, the truncated mutant promotes
the formation of polyubiquitin chains, as indicated by the
loss of activity in reactions with methyl-ubiquitin (Fig-
ure 5A). We also tested the linkage specificity and again
observed a complete preference for K48-linked chains in
the absence of the UBA domain. We conclude that the
UBA domain contributes to polyubiquitin chain assembly
but that the core UBC domain determines specificity for
the lysine on ubiquitin.
We also compared the rates and products of the
ubiquitination reactions at different concentrations of
wild-type and truncated Ubc1 (Figures 5B and 5C). Half-
maximal stimulation of cyclin turnover with Ubc1-DUBA
occurred at 10-fold higher concentrations than those for
Ubc1 (Figure 5D), suggesting that Ubc1-DUBA has a lower
affinity for the APC or substrate. Interestingly, maximal
activity varied in the opposite manner, with Ubc1-DUBA
having a 10-fold higher Vmax than Ubc1, resulting in
identical kcat/K1/2 values. In a comparison of processivitiesCell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc. 131
Figure 4. Ubc1 Catalyzes Rapid Ubiquiti-
nation of Preubiquitinated Species
Mono- and diubiquitinated 125I-cyclin were
prepared by subjecting a large Ubc4-
APCCdh1-dependent reaction to SDS-PAGE
and extracting reaction products from excised
gel fragments. Recombinant Ubc4 ([A], 1.25 mg)
or Ubc1 ([B], 1.25 mg) was combined with E1,
ATP, and ubiquitin and added to APCCdh1
mixes containing the indicated substrate. After
the indicated times, reactions were stopped by
addition of SDS sample buffer, analyzed by
SDS-PAGE, and visualized with a Phosphor-
Imager.
(C and D) Cyclin turnover and ubiquitin incorpo-
ration weremeasured for reactions using cyclin
and monoubiquitinated cyclin as starting sub-
strates. Note that in (D) the two Ubc4 curves
are superimposed.
(E) APC reactions were carried out in the
presence of Ubc4 (0.5 mg), Ubc1 (0.5 mg), or
a combination of both enzymes at these con-
centrations. After the indicated times, reactions
were stopped by addition of SDS sample
buffer, analyzed by SDS-PAGE, and visualized
with a PhosphorImager.
(F) The amount of ubiquitinated products above
the triubiquitinated species was quantified
using ImageQuant.
(G) All ubiquitinated products were quantified,
providing a measure of the total amount of
cyclin converted to ubiquitinated species.(Figure 5E), Ubc1 reached a higher value at a lower E2
concentration than Ubc1-DUBA, with the latter never
able to achieve the processivity of Ubc1. We therefore
suspect that Ubc1-DUBA has a defect in binding to the
APC-substrate complex (resulting in a processivity defect)
but is not defective in catalysis or linkage specificity. The
high cyclin-depleting activity of Ubc1-DUBA may indicate
that the UBA domain reduces activity toward unmodified
targets, and in its absence this restriction is relaxed.
Human E2-25K Promotes Modification
of Preubiquitinated APC Targets
Our studies of yeast Ubc1 raised the possibility that higher
eukaryotes might also employ an E2 that is specialized
for the second, K48-specific, step in polyubiquitin chain
assembly on APC substrates. On the basis of amino
acid sequence, the closest human homolog of yeast
Ubc1 is E2-25K/Hip2, a well-known E2 that was among
the first to be characterized in biochemical detail (Chen
and Pickart, 1990; Chen et al., 1991). Like Ubc1, E2-25K132 Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc.contains a C-terminal UBA domain (Haldeman et al.,
1997; Merkley and Shaw, 2004) and is known to catalyze
the formation of unanchored K48-linked polyubiquitin
chains (Chen and Pickart, 1990). Little is known about its
biological function or E3 partners; recent studies suggest
that E2-25K, like yeast Ubc1, may serve as an E2 for
E3s involved in the ER-associated degradation (ERAD)
pathway (Flierman et al., 2006). Thus, there are clearly
many parallels between yeast Ubc1 and human E2-
25K, suggesting that E2-25K may contribute to APC
function.
We tested the activity of E2-25K with APCCdh1 immuno-
purified from extracts of human HeLa cells (Figure 6A) or
from frog embryonic cells (data not shown). In both cases,
E2-25K displayed low but reproducible activity with
unmodified substrates, including cyclin (Figure 6A) and
securin (data not shown). More importantly, we noted
that mixing E2-25K with human UbcH10 consistently
resulted in greater polyubiquitination of substrates than
was achieved with UbcH10 alone (Figure 6A), suggesting
Figure 5. The UBA Domain of Ubc1
Participates in Processivity
(A) Reactions were carried out as in Figures 2A
and 2B. Ubc1 (1.25 mg) or Ubc1-DUBA
(1.25 mg) was incubated with the indicated
ubiquitin species in an APCCdh1-dependent
reaction with 125I-cyclin. Reaction products
were analyzed by SDS-PAGE and visualized
with a PhosphorImager.
(B and C) Recombinant Ubc1 (6.6 nM to 66 mM
in equal steps) or Ubc1-DUBA (6.6 nM to 66 mM
in equal steps) was used in APCCdh1 ubiquitina-
tion assays as in Figure 3A.
(D and E) Total cyclin turnover and reaction
processivity were measured as described in
Figures 3B and 3C.that E2-25K, like Ubc1, might be specialized for the
modification of substrates carrying preattached ubiqui-
tins. We therefore measured E2-25K activity toward cyclin
that was already modified with one or two ubiquitins, as in
our studies of Ubc1. The activity of E2-25Kwas stimulated
about 3-fold by the presence of one ubiquitin on the
substrate, and two ubiquitins resulted in a dramatic 15-
fold increase in activity (Figure 6B, top). Thus, E2-25K,
like Ubc1, displays a clear preference for preubiquitinated
targets and iswell suited for the second step in polyubiqui-
tin chain formation. Because E2-25K is known to possess
E3-independent ubiquitin chain-forming activity (Chen
and Pickart, 1990), we also analyzed its activity in the
absence of APC (Figure 6B, bottom). A low level of activity
was detected, but the addition of APC increased this
activity 6- to 8-fold with any of the three substrates. We
therefore conclude that E2-25K behaves much like Ubc1
and might therefore serve as an APC-dependent chain-
extending E2 in human cells.
Ubc1 and Ubc4 Are Required for APC Function
In Vivo
A prediction from our studies in vitro is that both Ubc1 and
Ubc4 collaborate with the APC in the yeast cell to promote
ubiquitination of substrates important for cell-cycle pro-
gression. Previous studies have shown that Ubc4 is not
required for the efficient degradation of mitotic cyclins
(Townsley and Ruderman, 1998), but the contribution of
Ubc1 to APC function has not been assessed. We first
characterized the effects of deleting the UBC1 gene and
found that Ubc1 is essential in our strain background
(W303). We therefore turned to conditional expression of
UBC1 by placing the chromosomal copy of UBC1 under
the control of the PGAL1 promoter, with a 3xHA tag at the
protein’s N terminus. This strain was viable on media
containing galactose but displayed a severe growth
defect when UBC1 expression was repressed on media
containing glucose (Figure 7A). When we streaked for sin-gle cells on dextrose plates, we observed multiple rounds
of division, resulting in microcolonies containing filamen-
tous clusters of cells lacking a uniform bud-size pheno-
type (data not shown). We also constructed a PGAL1UBC1
strain in which UBC4 was deleted. When plated on re-
pressive glucose media, this double mutant strain was
completely inviable (Figure 7A).
Loss of APC function is known to result in a metaphase
arrest with high levels of securin and mitotic cyclins. Dele-
tion of all APC-dependent E2s should generate a similar
phenotype unless those E2s have important collabora-
tions with E3s involved in other processes. To further
analyze the cell-cycle defects in the PGAL1UBC1 and
PGAL1UBC1 ubc4D strains, cells were arrested in G1
with a factor in the presence of galactose. Glucose was
added to repress UBC1 transcription, and after two hours
cells were released from the a factor arrest into media
containing glucose. No Ubc1 was detectable by western
blotting of lysates from either strain (Figure 7B, Ubc1
western). We compared cell-cycle events and APC
substrate levels in wild-type, PGAL1UBC1, ubc4D, and
PGAL1UBC1 ubc4D cells (Figure 7B).
Cells lacking UBC1 alone displayed several mitotic
defects. Analysis of DNA and spindle morphology re-
vealed a delay in the initiation of spindle elongation and
chromosome segregation as well as a delay in spindle
disassembly. The final step in cell separation was highly
defective, as indicated by the observation that the two
daughter cells remained connected to the end of the
experiment. This connection could be severed by digest-
ing the cell wall with zymolyase. Analysis of APC substrate
levels was consistent with these phenotypes: securin
accumulated to abnormally high levels and was destroyed
only after a delay, while the destruction of Clb2 and Cdc20
was completely blocked. Ubc1 is therefore required for
the normal destruction of APC targets and is particularly
critical for that of Clb2, resulting in various partial defects
in late mitotic events.Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc. 133
Cells lackingUBC4 also displayed defects in latemitotic
events, including delays in anaphase onset and spindle
disassembly that were accompanied by partial defects
in the destruction of securin and Clb2 (Figure 7B). Double
mutants lacking bothUBC1 andUBC4 displayedmore se-
vere defects than either single mutant. Themetaphase-to-
anaphase transition was completely blocked, resulting in
a complete arrest with a single DNAmass over a short pre-
anaphase spindle at the bud neck. All APC substrates
tested were stabilized in this arrest. Ubc1 and Ubc4 are
therefore required for APC activity during mitosis.
We also analyzed cell-cycle progression in PGAL1UBC1
ubc5D and PGAL1UBC1 ubc11D cells. When these cells
were released from a G1 arrest in the presence of glucose
to repress UBC1 expression, the mitotic defects in double
mutants were the same as those in the absence of UBC1
alone (data not shown). Thus, Ubc5 and Ubc11 do not
Figure 6. Human E2-25K Catalyzes APC-Dependent Modifi-
cation of Preubiquitinated Species
(A) Purified UbcH10 (1 mg), E2-25K (4 mg, 8 mg), or the indicated
combinations were conjugated to ubiquitin by incubation with mam-
malian E1 (0.55 mg for UbcH10 and 1.1 mg for E2-25K and the combi-
nation), ATP, and ubiquitin. E2-ubiquitin conjugates were then incu-
bated with immunopurified human APC supplemented with human
Cdh1 and 125I-cyclin. Reaction products were analyzed by SDS-PAGE
and visualized with a PhosphorImager. Control reactions (first lane)
lacked E2 protein.
(B) Mono- and diubiquitinated 125I-cyclin were prepared as described
in Figure 4. E2-25K (4 mg) was incubated with E1, ATP, and ubiquitin
and added to human APC supplemented with Cdh1 and the indicated
substrate (top). Control reactions (bottom) weremixedwith buffer lack-
ing APCCdh1. After the indicated times at 37C, reactions were stopped
by addition of SDS sample buffer, analyzed by SDS-PAGE, and visual-
ized with a PhosphorImager. Note that a deubiquitinating activity
copurifies with the APC in these experiments, resulting in some loss
of ubiquitin during the reaction.134 Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc.make significant contributions to APC function in the
absence of Ubc1.
Our observation that cells lacking UBC1 are particularly
defective in Clb2 destruction and late mitotic events
suggested that the inviability of this strain is due primarily
to defects in Cdk1 inactivation in late mitosis. Consistent
with this possibility, we found that PGAL1UBC1 cells are
viable on glucose plates when they are engineered to
express high levels of the Cdk inhibitor Sic1 (Figure S3).
DISCUSSION
The biochemical features of Ubc4 and Ubc1 suggest that
they operate in sequence to promote the two steps of
polyubiquitination: Ubc4 is best suited for the nonspecific
monoubiquitination of multiple lysines in the target, yield-
ing an ideal substrate upon which Ubc1 can assemble
K48-linked polyubiquitin chains.
The K48 linkage specificity of Ubc1 is not affected by
removal of its C-terminal UBA domain, indicating that
specificity is determined by the core ubiquitin-conjugating
domain. The K48-linkage specificity of Cdc34 (Ubc3), the
primary E2 for the ubiquitin-protein ligase SCF, depends
on an acidic loop near its catalytic cysteine (Petroski and
Deshaies, 2005). This loop is not present in Ubc1, and
so the sequence determinants of Ubc1 specificity remain
unclear.
Removal of the UBA domain results in shorter reaction
products than those seen with wild-type Ubc1. In addi-
tion, the concentration of Ubc1-DUBA required for half-
maximal activity is far higher than that for the wild-type
protein. A likely explanation for these results is that the
UBA domain interacts with ubiquitin on a preubiquitinated
target, thereby enhancing the affinity of Ubc1 for the APC-
substrate complex. It remains unclear if Ubc1 promotes
modification of K48 in the UBA-bound ubiquitin itself or
in an adjacent ubiquitin. Even if the substrate carries
only a single ubiquitin, the interaction of that ubiquitin
with Ubc1 might stimulate monoubiquitination of nearby
lysines in the target protein, resulting in additional sub-
strates upon which chains can be built.
Ubc1 and Ubc4 Collaborate In Vivo to Promote APC
Target Destruction
Our studies of ubc1D and ubc4D cells indicate that the
sequential actions of the two E2s are critical for the normal
timing of mitotic events: the loss of either E2 results in the
partial stabilization of APC substrates and delays in the
onset and completion of anaphase and other events.
The loss of both Ubc1 and Ubc4 results in a complete
arrest in metaphase, clearly arguing that these two pro-
teins alone serve as the E2 partners for the APC in the
mitotically proliferating yeast cell.
Repression of UBC1 expression results in a late mitotic
arrest that appears to be due primarily to a defect in Clb2
destruction and thus Cdk1 inactivation, as it is suppressed
by overproduction of the Cdk1 inhibitor Sic1. This pheno-
type appears to be a less severe form of the phenotype
Figure 7. Ubc4 and Ubc1 Are the Only
E2s Required for APC Function In Vivo
(A) The indicated strains were grown in 2%
galactose to midlog phase. 107 cells were
centrifuged and serially diluted onto plates
containing galactose or glucose and incubated
at 30C for two days.
(B) Asynchronous cultures of the indicated cells
(5 hr time point) were treated with a factor for
3 hr (2 hr time point), after which glucose was
added for 2 hr. Alpha factor was then washed
out (zero time point), and at the indicated times
cells were analyzed directly for budding index
(black squares). Parallel samples were fixed
and treated with zymolyase for analysis of
DNA masses with DAPI staining and spindle
structure with anti-tubulin antibodies, allowing
measurement of chromosome segregation
(binucleate cells, white circles) and elongated
anaphase spindles (black triangles). Additional
samples were prepared for western blotting
analysis of the indicated proteins. Note that
budding index is generally higher than the per-
centage of binucleate cells because chromo-
some masses, but not budding, were counted
after treatment with zymolyase, which sepa-
rates cells connected only by the cell wall.that results from expression of a nondegradable Clb2 mu-
tant, which is also rescued by Sic1 overproduction (Wa¨sch
and Cross, 2002). Given that Clb2 destruction depends
partly on Cdc20 and that Cdh1 is not essential for viability,
these results argue that the ubc1D phenotype is not sim-
ply the result of a defect in Cdh1-specific APC activity.
Cells lacking Ubc4 alone display a minor mitotic delay
but eventually degrade all major APC targets; thus, the
poormonoubiquitination activity of Ubc1may be sufficientin vivo, or other factors in the cell may boost this activity.
Cells lacking Ubc1 alone display a more pronounced
defect in APC-dependent protein destruction: these cells
eventually degrade securin and Clb5 but not Cdc20 and
Clb2. When UBC4 is also deleted, destruction of all major
APC targets is blocked. Thus, Ubc4 alone appears capa-
ble of promoting the destruction of some APC targets
despite its poor polyubiquitin chain-forming activity. As
suggested recently, an array of short chains producedCell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc. 135
byUbc4-APCmay be sufficient to target some proteins for
destruction (Kirkpatrick et al., 2006). Alternatively, chain-
extending activities or E4s (Hoppe, 2005) may assist
Ubc4-APC in the polyubiquitination of some targets.
These mechanisms may explain why securin is eventually
destroyed in the absence of Ubc1, but it remains unclear
why Clb2 and Cdc20 remain stable. One possibility is
that Clb2 and Cdc20 are relatively poor substrates of
APC-Ubc4, so that their rate of ubiquitination is insufficient
to oppose the rate of deubiquitination in the cell. The tim-
ing of substrate destruction in vivo is likely to depend, at
least in part, on the processivity of substrate ubiquitination
by the APC (Rape et al., 2006), and the processivity of
Clb2 and Cdc20 ubiquitination by APC-Ubc4 may not be
sufficient for its destruction in vivo.
E2s other than Ubc4 and Ubc1 do not appear to make
significant contributions to mitotic APC activity. We did
find, however, that Ubc5 andUbc11 catalyze APC-depen-
dent monoubiquitination in vitro. Interestingly, expression
of the genes encoding these two proteins is induced upon
entry intomeiosis, whereasUBC4 expression is repressed
(Chu et al., 1998). Perhaps one or both of these E2s fulfils
the role of Ubc4 in the meiotic program.
Sequential E2 Action May Be a Conserved
Mechanism in APC Function
Our work is reminiscent of previous studies in fission
yeast, where two E2s have been implicated in cyclin
destruction and mitotic progression (Seino et al., 2003).
Depletion of the Ubc4 homolog, UbcP1, leads to the accu-
mulation of low molecular weight cyclin-ubiquitin species
in vivo, while depletion of a UbcH10 homolog, UbcP4,
results in the accumulation of nonubiquitinated cyclin.
These results are consistent with the possibility that the
two E2s generate different products, but detailed bio-
chemical studies of these products have not been per-
formed. The vertebrate homologs of these E2s, UbcH5
and UbcH10, are not believed to generate extensive poly-
ubiquitin chains (Kirkpatrick et al., 2006), and so it remains
possible that UbcP1 and UbcP4 are supplemented by
a fission yeast Ubc1 homolog or some other chain-
extending activity.
In vertebrates, UbcH5 and UbcH10 are thought to be
the two major E2s that collaborate with the APC. Both
were identified biochemically as the major APC-depen-
dent E2 activities in extracts of frog and clam embryos
(Aristarkhov et al., 1996; King et al., 1995; Yu et al., 1996).
RNAi-mediated depletion of UbcH10 from human cells, or
the homologous protein, Vihar, in Drosophila causes par-
tial mitotic defects accompanied by stabilization of APC
targets (Mathe et al., 2004; Rape and Kirschner, 2004).
Apart from these experiments, there has been no system-
atic analysis in higher eukaryotes of the requirement for
different E2s in APC function, and there is no evidence
to rule out the possibility that E2s other than UbcH5 and
UbcH10 are involved.
Our studies suggest that E2-25K also contributes to
APC function in vertebrate cells. E2-25K is the closest136 Cell 130, 127–139, July 13, 2007 ª2007 Elsevier Inc.human homolog of Ubc1 by sequence, and it shares
many other features with yeast Ubc1: it catalyzes K48-
linked polyubiquitin formation (Chen and Pickart, 1990),
it contains a UBA domain at its C terminus (Haldeman
et al., 1997), and it has been implicated in the ERAD path-
way (Flierman et al., 2006). We found that E2-25K is an
effective catalyst of APC-dependent ubiquitination of sub-
strates carrying preattached ubiquitins. It has little activity
with unmodified substrates, perhaps explainingwhy it was
never identified as a major APC-dependent E2 activity in
previous biochemical studies. We therefore speculate
that sequential E2s operate in human cells as in yeast:
UbcH5 and UbcH10 may add the first ubiquitins to APC
targets, after which E2-25K extends K48-linked chains
on those ubiquitins.
Sequential E2 Action as a General Mechanism
in Polyubiquitin Chain Formation
Our work reveals how the APC solves an important
general problem in the mechanism of protein polyubiquiti-
nation: how a single E3 can efficiently promote both
monoubiquitination of nonspecific lysines in a target and
highly specific K48 ubiquitination of ubiquitins on that tar-
get. The strategy used by the APC to solve this problem—a
pair of E2s, each specialized for one of the two steps in
chain formation—contrasts with the strategy used by the
related E3, SCF, which employs a single E2, Cdc34, to
catalyze both steps. What advantage might there be to
using two E2s instead of one? One possibility is that two
specialized E2s allow more rapid polyubiquitination than
a single E2. In the case of Cdc34, for example, the initial
monoubiquitination step is slow and limits the overall
rate of polyubiquitination; in the case of the APC, this
problem is solved by introducing a second E2, Ubc4,
that drives rapid nonspecific monoubiquitination of
targets. We speculate that it would be difficult to evolve
a single E2 that is efficient at both steps in chain formation:
the first step requires a flexible active site environment
that allows any lysine to attack, while the second step
requires a more selective active site that channels lysine
48 of ubiquitin for attack.
The use of sequential E2s may be a general mechanism
in polyubiquitin chain assembly by other E3s. There are
numerous examples of ubiquitin-dependent degradation
processes that appear to depend on multiple E2s. For
example, Ubc7, Ubc6, and Ubc1 all contribute to the deg-
radation of proteins in the yeast ERAD pathway (Meusser
et al., 2005), and human ERAD may depend on homologs
of Ubc1 and Ubc7 (Flierman et al., 2006). In these and
other cases, different E2s may display distinct biochemi-
cal features that together allow more efficient polyubiqui-
tination than is possible with a single E2.
EXPERIMENTAL PROCEDURES
Strains and Plasmids
All yeast strains were derived from W303 except for strains from
the TAP library. PGAL13xHA-UBC1 was constructed by standard
PCR-targeting techniques by direct replacement of theUBC1 promoter
with the GAL1 promoter and 3xHA sequence (Longtine et al., 1998).
Construction of Ubc1 and Ubc4 for protein expression was carried out
by standard techniques. UBC1 and UBC4 were PCR-amplified lacking
the stop codon and were ligated into the pET23d vector to generate
a C-terminally 6xHis tagged protein. UBC1 was PCR amplified using
an internal 30 oligonucleotide to create Ubc1-DUBA (residues 1–150).
Expression and Purification of E2 Proteins
Yeast strains expressing C-terminally TAP-tagged UBC genes were
obtained from the library constructed at UCSF (Ghaemmaghami
et al., 2003). One liter cultures were grown to an OD600 of 1.0, har-
vested, and lysed by bead-beating into 2.5 volumes of TAP lysis buffer
(20 mMHEPES pH 8.0, 150mMNaCl, 0.1%NP40) supplemented with
50mM b-glycerophosphate, 50 mMNaF, 1mMDTT, 1mMPMSF, and
1 mg/ml each of aprotinin, pepstatin, and leupeptin. Lysate was clari-
fied by ultracentrifugation (1 hr, 100,000 3 g, 4C) and added to 50 ml
of IgG beads pre-equilibrated in TAP lysis buffer. After an overnight
incubation at 4C, beads were washed twice in TAP lysis buffer and
once in TEV cleavage buffer (TAP lysis buffer plus 0.5 mM EDTA and
1 mM DTT). Beads were incubated 30 min at room temperature in
50 ml of TEV cleavage buffer and 2 ml of recombinant TEV protease,
and cleaved proteins were recovered for ubiquitination assays.
For bacterial expression, plasmids containing C-terminally tagged
UBC1 and UBC4 were transformed into BL21 cells. A single colony
for each gene was incubated overnight in 100 ml LB/Amp media at
37C, diluted into 1 l of fresh media, and grown at 37C to an OD600
of 0.60, after which IPTG was added to 1 mM for 4 hr at 37C. Cells
were harvested by centrifugation, washed in cold water, and frozen
in liquid nitrogen. Frozen pellets were melted rapidly and dripped
into a mortar containing liquid nitrogen, where they were ground with
a pestle to a fine powder. The powder was added to 4 volumes of
breakage buffer (50 mM HEPES pH 7.4, 300 mM NaCl, 10% Glycerol
plus protease inhibitors lacking DTT or any reducing agent), and the
mixture was sonicated five times for 30 s each, alternating with 45 s
breaks. Lysates were centrifuged (1 hr, 100,000 3 g, 4C), and
supernatants were subjected to purification by metal affinity chroma-
tography on a 1 ml Pharmacia Hi-Trap column charged with Co+2.
Fractions containing purified protein were pooled and dialyzed into
QAH buffer (50 mM HEPES pH 7.4, 100 mM NaCl, 1 mM MgCl2) plus
10% glycerol and 1 mM b-mercapto-ethanol. The resulting stocks of
Ubc1 (5 mg/ml), Ubc4 (2.5 mg/ml), and Ubc1-DUBA (5 mg/ml) were
stored at 80C.
Ubiquitination Assays
Preparation of reaction components (E1, ATP, Ubiquitin, APC, Cdh1)
was described previously (Carroll and Morgan, 2005), except that
the final calmodulin-binding step was omitted from the APC prepara-
tion. To prepare ubiquitin-E2 conjugates, E1 (0.2 ml of 1 mg/ml), ATP
(1.0 ml of 16.7 mM), and ubiquitin (1.5 ml of 10 mg/ml) were incubated
with E2 proteins for 15 min at room temperature. In separate tubes,
APC (1.5 ml of 10 nM), Cdh1 (0.5 ml of 1.5 mM), and radiolabeled sub-
strate were mixed at room temperature. Reactions were initiated by
combining the E1/E2 mix with the APC mix in a final volume of 20 ml,
except for dose response assays in Figures 3 and 5 (10 ml final volume).
Reaction products were analyzed by SDS-PAGE and visualized with
a PhosphorImager. Data were quantified as described using Image-
Quant and analyzed using the ligand-binding module of SigmaPlot
(Carroll and Morgan, 2005). The expression, purification, and labeling
of the N terminus of sea urchin cyclin B has been described previously
(Carroll and Morgan, 2005). All other substrates were produced by
coupled transcription and translation in rabbit reticulocyte extracts.
Unless specified, substrates produced by this method were not
purified; instead, the TNT mixture was treated with NEM prior to ubiq-
uitination reactions, which we find inactivates chain-extending activi-
ties present in the lysate. Purification of preubiquitinated cyclin B
species was described previously (Carroll and Morgan, 2002).Cell Cycle Analysis
Strains were grown at room temperature and arrested in G1 by the
addition of a factor (1 mg/ml) for 3 hr in the presence of 2% raffinose
and 2% galactose. Two percent glucose was added to all strains for
another 2 hr. Cells were washed free of a factor and placed in fresh
media containing 2% glucose, and samples were taken every
15 min. Alpha factor (1 mg/ml) was added back after 90% of the cells
had budded. Protein extracts were prepared by bead-beating in urea
lysis buffer. 3HA-Ubc1 was detected on western blots with 12CA5
monoclonal antibody (Roche). Securin-13Myc was detected with
9E10 monoclonal antibody. Cdc20 and Clb5 were detected with poly-
clonal antibodies (Santa Cruz BioTech). Polyclonal anti-Clb2 anti-
bodies were a generous gift of Doug Kellogg (University of California,
Santa Cruz). DNA was visualized by DAPI staining, and tubulin was
visualized by indirect immunofluorescence with antibody YOL1/34
using spheroplasts. The percentage of budded cells was measured
from intact cells fixed in ethanol.
Human APC Analysis
HeLa cells were grown, and lysates were prepared, as previously
described (Kraft et al., 2006). Twenty 15 cm dishes of confluent cells
were lysed in 5 ml HeLa lysis buffer (20 mM HEPES pH 7.4, 150 mM
NaCl, 20 mM b-glycerophosphate, 5 mM MgCl2, 1 mM NaF, 0.2%
NP-40, 10% Glycerol) plus protease and phosphatase inhibitors. The
lysate was clarified by centrifugation (1 hr, 100,000 3 g, 4C); final
protein concentration was 18mg/ml. APC was purified by immunopre-
cipitation as follows. Fifty microliters of rabbit anti-Cdc27 antiserum
were incubated with 125 ml protein A magnetic beads (Dynal, Invitro-
gen) for 30 min at room temperature. After one wash in HeLa lysis
buffer, 15 mg of lysate were added to the beads and incubated with
rocking for 2 hr at 4C. Beads were washed once with wash buffer
(20 mM HEPES pH 7.4, 150 mM NaCl, 0.1% NP-40, 10% Glycerol),
twice with wash buffer plus 600 mM NaCl, and once more with wash
buffer. Beads were resuspended in 100 ml of wash buffer and distrib-
uted into ten ubiquitination reactions. To prepare ubiquitin-E2 conju-
gates, mammalian E1 (0.55 mg/ml, Boston Biochem), ATP (2.0 ml of
16.7 mM), and ubiquitin (1.5 ml of 10 mg/ml) were incubated 20 min
at room temperature with each E2 protein (purified human E2-25K
and UbcH10were gifts of Vincent Chau and Hongtao Yu, respectively).
After confirming by gel electrophoresis that ubiquitin conjugation had
occurred, E2-ubiquitin conjugates were mixed with human Cdh1
(1.0 ml, a gift of Hongtao Yu), radiolabeled substrate (2.0 ml), and
bead-bound human APC (10 ml). Reactions (23 ml) were incubated
1 hr at 37C.
Supplemental Data
Supplemental Data include three figures and can be found with this
article online at http://www.cell.com/cgi/content/full/130/1/127/DC1/.
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